“…[64] Thus, the in silico calculations suggested major groove of DNA strands and subdomain IB of HSA as the main binding sites for the [Ru 2 O(keto) 2 (py) 6 ](PF 6 ) 2 compound. The same trend for both DNA and HSA was previously observed in silico for some other ruthenium complexes, including Ru(II)-polypyridyl [Ru(NÀ N) 2 (PTCP)](ClO 4 ) 2 (where NÀ N : 1,10-phenanthroline; 2,9-dimethyl-1,10-phenanthroline, or 4,40-di-tert-butyl-2,20-bipyridine), [65] meso-tetra(4pyridylvinylphenyl)porphyrin functionalized with [Ru(bpy) 2 Cl] + units, [66] 10,15,20-tetrakis(4-pyridyl)-21H,23H-porphyrin functionalized with [Ru(bpy) 2 Cl] + units, [67] [Ru(tmp) 2 (dpq)] 2 + , [Ru-(tmp) 2 (dppz)] 2 + , and [Ru(tmp) 2 (11,12-dmdppz)] 2 + . [68] Aditionally, the highest docking score value for HSA compared with DNA suggested that [Ru 2 O(keto) 2 (py) 6 ](PF 6 ) 2 interacts stronger with albumin than with DNA, being in agreement with the experimental trend, as well as the experimental number of binding site indicated a proportion HSA:[Ru 2 O(keto) 2 (py) 6 ](PF 6 ) 2 of 1 : 1 and molecular docking score values for albumin clearly show a high difference among the three binding sites, also indicating one main binding site.…”